Want to see AU:ANN full AI Analyst Report?
Top Page
Ansell
(Sydney:ANN)
Select Model
Select Model
Rating:72Outperform
Price Target:
AU$51.00
▲(23.31% Upside)
Action:Reiterated
Date:08/26/26
The score is driven primarily by improved financial performance (margin expansion and sharply stronger free cash flow) and a constructive earnings outlook with positive execution and guidance. Technicals are supportive but tempered by an overbought RSI, and valuation appears fair rather than compelling.
Positive Factors
Sales growth and market momentum
Broad-based sales growth, accelerating second-half volume trends, and strong U.S. performance indicate improving customer demand across important markets. Continued momentum supports operating leverage, strengthens Ansell’s commercial position, and provides a durable base for further earnings growth.
Negative Factors
Uneven revenue and volume trajectory
Recent growth has improved, but uneven historical revenue and slightly lower full-year volumes show that demand has not advanced consistently. This variability can make capacity planning, margin progression, and earnings forecasting less dependable over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Sales growth and market momentum
Broad-based sales growth, accelerating second-half volume trends, and strong U.S. performance indicate improving customer demand across important markets. Continued momentum supports operating leverage, strengthens Ansell’s commercial position, and provides a durable base for further earnings growth.
Read all positive factors
Ansell (ANN) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$6.49B
Dividend Yield2.06%
Average Volume (3M)567.10K
Price to Earnings (P/E)22.0
Beta (1Y)1.11
Revenue Growth1.90%
EPS Growth99.19%
CountryAU
Employees15,000
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)1.46
Shares Outstanding140,313,830
10 Day Avg. Volume681,646
30 Day Avg. Volume567,099
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)1.58
Price to Sales (P/S)1.43
P/FCF Ratio10.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$39.38Price Target Upside-4.78% Downside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.64
Revenue Forecast (FY)AU$2.23B
Ansell Business Overview & Revenue Model
Company Description
Ansell Limited is a global enterprise that conceptualizes, innovates, and produces protective equipment for various industries across numerous regions, including Asia Pacific, Europe, the Middle East, Africa, the Americas, and the Caribbean. The c...
How the Company Makes Money
Ansell makes money primarily by selling PPE—most importantly protective gloves—into two broad end markets: (1) healthcare and (2) industrial/specialty industrial. Revenue is generated through product sales to hospitals and healthcare systems, grou...
Ansell Earnings Call Summary
Earnings Call Date:Aug 23, 2026
(Q4-2026)
| Next Earnings Date:Feb 22, 2027
Earnings Call Sentiment Positive
The call presented a clear majority of positive operational and financial outcomes — double-digit EPS growth, higher margins, strong cash conversion, U.S. and Cleanroom-led sales momentum, recurring cost savings (APIP $50M) and improved balance sheet metrics. Management also acknowledged and proactively managed notable headwinds (Middle East cost inflation, U.S. tariffs, commodity volatility, FX hedge losses and non‑cash impairments), and provided a constructive FY'27 EPS guidance range of $1.58–$1.70 with assumptions of continued volume/price momentum and ~$9M FX tailwind. On balance the positives — strong execution, margin expansion, cash generation and concrete operational improvements — outweigh the transient and manageable risks cited.Positive Updates
Top-line growth and second-half momentum
Adjusted net sales grew 5.7% for FY'26 (ex-FX and product exits). Second-half growth accelerated to 9.2%, driven by improving volume trends.
Negative Updates
Middle East crisis cost volatility and ongoing uncertainty
Middle East conflict caused raw material and cost inflation; management passed costs to customers to offset impacts but emphasized continued uncertainty and the need for flexible pricing going forward.
Read all updates
Q4-2026 Updates
Positive
Negative
Top-line growth and second-half momentum
Adjusted net sales grew 5.7% for FY'26 (ex-FX and product exits). Second-half growth accelerated to 9.2%, driven by improving volume trends.
Read all positive updates
Company Guidance
Ansell guided adjusted EPS of $1.58–$1.70 for FY27 (FY26 adjusted EPS $1.486), implying ~6.4%–14.4% upside (midpoint ~$1.64, ≈10.3% growth), on assumptions of continued sales momentum from both volume and pricing, focus on higher‑margin markets/brands and ongoing commercial and operational excellence; management also factored in a $9m FX benefit versus FY25. They expect GPADE and margin improvement from mix and productivity, SG&A to be managed around prior‑year growth (~2.7%), lower net capex than FY26 ($48.6m) with targeted strategic investment, continuation of the on‑market buyback program, and a conservative funding profile (net debt/EBITDA target 1.5–2.5x, currently 1.3x) with $752m of cash and undrawn facilities — while noting macro uncertainty.Ansell Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
70
Positive
Cash Flow
78
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.19B | 2.00B | 1.62B | 1.66B | 1.95B |
| Gross Profit | 906.27M | 825.00M | 624.80M | 616.70M | 625.19M |
| EBITDA | 424.72M | 257.28M | 202.30M | 276.28M | 298.84M |
| Net Income | 213.18M | 101.60M | 76.50M | 148.30M | 158.70M |
Balance Sheet | |||||
| Total Assets | 3.39B | 3.32B | 3.24B | 2.52B | 2.51B |
| Cash, Cash Equivalents and Short-Term Investments | 249.39M | 238.30M | 912.30M | 159.03M | 206.18M |
| Total Debt | 756.27M | 805.60M | 857.20M | 493.15M | 485.74M |
| Total Liabilities | 1.37B | 1.34B | 1.33B | 913.07M | 949.48M |
| Stockholders Equity | 1.99B | 1.96B | 1.89B | 1.60B | 1.54B |
Cash Flow | |||||
| Free Cash Flow | 305.05M | 170.00M | 208.60M | 95.37M | 127.71M |
| Operating Cash Flow | 355.13M | 239.30M | 272.30M | 161.72M | 191.71M |
| Investing Cash Flow | -60.60M | -703.30M | -63.40M | -75.50M | -71.20M |
| Financing Cash Flow | -287.78M | -216.00M | 540.80M | -149.20M | -176.70M |
Ansell Technical Analysis
Positive
41.36
Price Trends
42.41
Positive
36.89
Positive
32.96
Positive
Market Momentum
1.11
Positive
71.11
Negative
74.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ANN, the sentiment is Positive. The current price of 41.36 is below the 20-day moving average (MA) of 45.36, below the 50-day MA of 42.41, and above the 200-day MA of 32.96, indicating a bullish trend. The MACD of 1.11 indicates Positive momentum. The RSI at 71.11 is Negative, neither overbought nor oversold. The STOCH value of 74.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ANN.
Ansell Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | AU$50.69B | 24.25 | 23.88% | 0.91% | 4.74% | 4.44% | |
72 Outperform | AU$6.49B | 22.01 | 10.52% | 2.06% | 1.90% | 99.19% | |
65 Neutral | AU$927.42M | 52.29 | 8.16% | ― | 2.59% | -13.36% | |
64 Neutral | AU$41.12M | 65.18 | 1.13% | 0.49% | 8.99% | 450.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$38.50M | -31.49 | -6.27% | ― | 0.29% | -148.39% | |
46 Neutral | AU$39.74M | -65.63 | -0.62% | ― | -3.05% | 86.01% |
* Healthcare Sector Average
AU:ANN
Ansell
46.50
13.56
41.19%
AU:NAN
Nanosonics Limited
3.10
-1.46
-32.02%
AU:MVP
Medical Developments International Limited
0.37
-0.32
-46.32%
AU:TRJ
Trajan Group Holdings Ltd
0.26
-0.54
-67.50%
AU:CSX
CleanSpace Holdings Ltd.
0.49
-0.21
-30.71%
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
35.84
-3.66
-9.27%
Ansell Corporate Events
Australian Retirement Trust exits substantial holder position in Ansell
Oct 26, 2026
Australian Retirement Trust Pty Ltd has notified Ansell Limited that it has ceased to be a substantial holder in the company as of 22 October 2026. The change reflects a reduction in its relevant interest in Ansell’s voting securities since ...
Host-Plus Sells Down Stake, Ceases to Be Substantial Holder in Ansell
Oct 21, 2026
Host-Plus Pty Limited has notified Ansell Limited that it has ceased to be a substantial shareholder in the company as of 16 October 2026. The change in Host-Plus’s relevant interest in Ansell’s voting securities was detailed in an ann...
Ansell Releases 2026 AGM Notice and Sets November Meeting Date
Oct 8, 2026
Ansell Limited has released its 2026 Notice of Annual General Meeting, along with related materials such as the Notice and Access Letter and Proxy Form, which are being distributed to shareholders. The AGM will be held on 9 November 2026 at the Pa...
Ansell Director Boosts Equity Stake Through Short-Term Incentive Award
Oct 7, 2026
Ansell has reported a change in the shareholdings of director Nathalie Ahlström, reflecting an increase in her equity stake in the company. The director now holds 6,118 ordinary shares in addition to 4,500 restricted stock units, signalling e...
Ansell Issues Unquoted Equity Under Employee Incentive Schemes
Oct 5, 2026
Ansell Limited has notified the ASX of the issue of new unquoted equity securities under its employee incentive schemes, comprising 181,397 restricted stock units and 382,029 performance share rights granted on 25 September 2026. These securities ...
Ansell Director Increases Indirect Shareholding via Voluntary Share Purchase Plan
Sep 28, 2026
Ansell Limited has disclosed a change in the indirect shareholding of director Randy Stone, following his participation in the company’s Voluntary Share Purchase Plan. The filing to the ASX shows Stone acquired 392 ordinary shares at a total...
Ansell Streamlines Capital Structure With Cessation of Incentive Securities
Sep 15, 2026
Ansell Limited has notified the market of the cessation of two classes of equity-based securities, restricted stock units and performance share rights, under ASX disclosure rules. The announcement details the removal of a combined 614,970 securiti...
Ansell Confirms FY26 Final Dividend Exchange Rate and DRP Price
Sep 10, 2026
Ansell Limited has updated its notification regarding the final dividend for the financial year ended 30 June 2026, covering the six-month reporting period. The company confirmed the applicable exchange rate for the FY26 final dividend and announc...
Ansell Sets 2026 AGM Date and Deadline for Director Nominations
Sep 10, 2026
Ansell Limited has scheduled its 2026 Annual General Meeting for 9 November 2026 at 9:00 a.m. AEDT, with detailed information about the meeting to be provided to shareholders in a forthcoming Notice of Meeting. The company has also set 21 Septembe...
Ansell Clarifies Exchange Rate for FY26 Final Dividend
Sep 1, 2026
Ansell Limited has updated its notification to shareholders regarding its final dividend for the 2026 financial year, specifying the exchange rate to be applied to the payout. The dividend relates to the six-month period ending 30 June 2026, with ...
Ansell Director Jonas Samuelson Initiates Stake with On-Market Share Purchase
Sep 1, 2026
Ansell Limited has disclosed a change in director Jonas Samuelson’s holdings, with the board member acquiring 3,750 ordinary shares in the company. The on-market purchase, valued at approximately $149,400, represents Samuelson’s first ...
Ansell Director Randy Stone Increases Indirect Shareholding via Voluntary Plan
Sep 1, 2026
Ansell reported a change in the shareholding of director Randy Stone, who increased his indirect interest in the company through the Voluntary Share Purchase Plan. The director acquired 420 ordinary shares, raising his indirect holding to 1,167 sh...
Ansell Director Debra Goodin Increases Indirect Shareholding via On-Market Purchase
Sep 1, 2026
Ansell Limited has reported a change in the indirect shareholding of non-executive director Debra Lyn Goodin through her beneficial interest in the DLG Super Fund. The disclosure reflects the company’s ongoing adherence to ASX listing rules ...
Ansell Releases FY26 ESG Report to Underscore Sustainability Commitments
Aug 31, 2026
Ansell Limited, a global supplier of personal protective equipment to healthcare and industrial customers, serves over 10 million workers across more than 100 countries through a broad portfolio of safety brands. The company emphasises innovation ...
Ansell Extends On‑Market Share Buy‑Back Program
Aug 23, 2026
Ansell Limited has announced an extension of its existing on-market buy-back of ordinary fully paid shares, originally notified in December 2025 and previously updated in June 2026. The latest notification confirms the continuation of the capital ...
Ansell Declares USD 0.415 Interim Dividend for June 2026 Period
Aug 23, 2026
Ansell Limited has declared a six‑month dividend on its ordinary fully paid shares, setting a distribution of USD 0.415 per share for the period ended June 30, 2026. The announcement underscores the company’s ongoing commitment to shar...
Ansell Details 2026 Corporate Governance Compliance in ASX Filing
Aug 23, 2026
Ansell has lodged its corporate governance statement for the year ended 30 June 2026 with the ASX and published it on its website, confirming board approval as of 24 August 2026. The statement sets out how the company has applied the ASX Corporate...
Ansell Details FY26 Corporate Governance and ASX Compliance
Aug 23, 2026
Ansell Limited released its FY26 Corporate Governance Statement, highlighting a comprehensive governance framework centred on an experienced board and multiple specialised committees overseeing risk, sustainability, human resources and audit. The ...
Ansell Highlights Use of Non-IFRS Metrics in FY26 Results and Stresses Investor Caution
Aug 23, 2026
Ansell Limited is a global provider of protective solutions, reporting its financial results under International Financial Reporting Standards. The company focuses on safety and protection products across industrial and healthcare settings, target...
Ansell Delivers Strong FY26 Growth as Higher-Value Safety Markets Drive Margins
Aug 23, 2026
Ansell reported strong FY26 performance, with sales rising to $2.14 billion, adjusted EBIT up 14.9% on an organic constant currency basis and adjusted EPS of 148.6 U.S. cents, near the top of guidance. Margin expansion was driven by greater sales ...
United Super exits substantial holder status in Ansell Limited
Aug 18, 2026
Ansell Limited has disclosed that United Super Pty Ltd has ceased to be a substantial shareholder in the company, following changes in its relevant interest in Ansell’s voting securities. The notice, lodged under Australia’s Corporatio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.